ACTA1 and neoplasm: In contrast to the enhanced anti-tumor effect observed in these studies, depletion of CAFs by targeting the less specific CAF marker, αSMA, resulted in enhanced tumor growth and immunosuppression via enhanced regulatory T cells [23].